Last 12 months
Inside the activity.
0 purchase rows · 17 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 4 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 31, 2021 Filed Apr 2, 2021 22:33 UTC |
WINSTON ROYChief Clinical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 13,750 | $0.00 Strike: $34.38 | $0.00 |
DisclosureSEC source: 0001209191-21-024791 · doc4.xml · derivative · entry 5 WINSTON ROY · CIK 0001751757 · Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 Underlying: Common Stock · 13,750 shares Expires 2028-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 22:33 UTC |
WINSTON ROYChief Clinical Officer
|
SaleCommon Stock | 1,200 | $72.12 | $86,544.00 |
DisclosureSEC source: 0001209191-21-024791 · doc4.xml · nonDerivative · entry 4 WINSTON ROY · CIK 0001751757 · Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,311 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $71.80 to $72.48, inclusive. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 22:33 UTC |
WINSTON ROYChief Clinical Officer
|
SaleCommon Stock | 4,661 | $71.09 | $331,350.49 |
DisclosureSEC source: 0001209191-21-024791 · doc4.xml · nonDerivative · entry 3 WINSTON ROY · CIK 0001751757 · Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,511 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $70.80 to $71.79, inclusive. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 22:33 UTC |
WINSTON ROYChief Clinical Officer
|
SaleCommon Stock | 16,363 | $70.36 | $1,151,300.68 |
DisclosureSEC source: 0001209191-21-024791 · doc4.xml · nonDerivative · entry 2 WINSTON ROY · CIK 0001751757 · Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,172 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.80 to $70.79, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 2 through 4. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 22:33 UTC |
WINSTON ROYChief Clinical Officer
|
Exercise / conversionCommon Stock | 13,750 | $34.38 | $472,656.25 |
DisclosureSEC source: 0001209191-21-024791 · doc4.xml · nonDerivative · entry 1 WINSTON ROY · CIK 0001751757 · Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,535 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| March 24, 2021 Filed May 13, 2021 18:01 UTC |
STACK DAVID MDirector · CEO and Chairman
|
GiftCommon Stock | 1,080 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-032424 · doc4.xml · nonDerivative · entry 1 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · By Three Colleens Investment, LLC Disclosed balance after: 97,273 F1 · ownership.nature: Mr. Stack and his wife are the owners of each of Three Colleens Investment, LLC and LCK Investment LLC. Mr. Stack is the general partner of Stack Schroon Mohawk FLP. Read SEC document |
| March 17, 2021 Filed Mar 18, 2021 00:03 UTC |
RIKER LAURENVice President, Finance
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $10.81 | $0.00 |
DisclosureSEC source: 0001209191-21-021585 · doc4.xml · derivative · entry 6 Riker Lauren Bullaro · CIK 0001545439 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,300 Underlying: Common Stock · 2,000 shares Expires 2022-06-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and vested as to the remaining shares in successive equal monthly installments for the subsequent 36 months. Read SEC document |
| March 17, 2021 Filed Mar 18, 2021 00:03 UTC |
RIKER LAURENVice President, Finance
|
SaleCommon Stock | 2,000 | $70.01 | $140,020.00 |
DisclosureSEC source: 0001209191-21-021585 · doc4.xml · nonDerivative · entry 4 Riker Lauren Bullaro · CIK 0001545439 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,181 F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $70.00 to $70.04, inclusive. Read SEC document |
| March 17, 2021 Filed Mar 18, 2021 00:03 UTC |
RIKER LAURENVice President, Finance
|
Exercise / conversionCommon Stock | 2,000 | $10.81 | $21,620.00 |
DisclosureSEC source: 0001209191-21-021585 · doc4.xml · nonDerivative · entry 3 Riker Lauren Bullaro · CIK 0001545439 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,181 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 01:12 UTC |
Wicki AndreasDirector
|
SaleCommon Stock | 10,601 | $73.68 | $781,081.68 |
DisclosureSEC source: 0001104659-21-037330 · tm219971-1_4seq1.xml · nonDerivative · entry 2 Wicki Andreas · CIK 0001511472 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 451,324 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.405 to $74.54, inclusive. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price within the ranges set forth in footnote three (3) of this Form 4. F2 · ownership.nature: These shares are held by HBM Healthcare Investments (Cayman) Ltd. ("HBM"), of which Mr. Wicki is a member of the board of directors. The board of directors of HBM acts by majority vote, and Mr. Wicki does not have sole voting or investment power with respect to the shares. Mr. Wicki disclaims beneficial ownership of such shares for the purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report on Form 4 shall not be deemed an admission that the reporting person is a beneficial owner for the purposes of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 20:01 UTC |
Froimson MarkDirector
|
SaleCommon Stock | 734 | $72.26 | $53,038.84 |
DisclosureSEC source: 0001209191-21-021583 · doc4.xml · nonDerivative · entry 1 Froimson Mark · CIK 0001709050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,242 Read SEC document |
| March 15, 2021 Filed Mar 18, 2021 00:03 UTC |
RIKER LAURENVice President, Finance
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,520 | $0.00 Strike: $10.81 | $0.00 |
DisclosureSEC source: 0001209191-21-021585 · doc4.xml · derivative · entry 5 Riker Lauren Bullaro · CIK 0001545439 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,300 Underlying: Common Stock · 1,520 shares Expires 2022-06-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and vested as to the remaining shares in successive equal monthly installments for the subsequent 36 months. Read SEC document |
| March 15, 2021 Filed Mar 18, 2021 00:03 UTC |
RIKER LAURENVice President, Finance
|
SaleCommon Stock | 1,520 | $73.28 | $111,385.60 |
DisclosureSEC source: 0001209191-21-021585 · doc4.xml · nonDerivative · entry 2 Riker Lauren Bullaro · CIK 0001545439 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,181 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.03 to $73.50, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 1 and 2. Read SEC document |
| March 15, 2021 Filed Mar 18, 2021 00:03 UTC |
RIKER LAURENVice President, Finance
|
Exercise / conversionCommon Stock | 1,520 | $10.81 | $16,431.20 |
DisclosureSEC source: 0001209191-21-021585 · doc4.xml · nonDerivative · entry 1 Riker Lauren Bullaro · CIK 0001545439 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,701 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2021 Filed Mar 17, 2021 01:12 UTC |
Wicki AndreasDirector
|
SaleCommon Stock | 58,754 | $73.10 | $4,294,917.40 |
DisclosureSEC source: 0001104659-21-037330 · tm219971-1_4seq1.xml · nonDerivative · entry 1 Wicki Andreas · CIK 0001511472 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 461,925 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.20 to $73.62, inclusive. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price within the ranges set forth in footnote one (1) of this Form 4. F2 · ownership.nature: These shares are held by HBM Healthcare Investments (Cayman) Ltd. ("HBM"), of which Mr. Wicki is a member of the board of directors. The board of directors of HBM acts by majority vote, and Mr. Wicki does not have sole voting or investment power with respect to the shares. Mr. Wicki disclaims beneficial ownership of such shares for the purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report on Form 4 shall not be deemed an admission that the reporting person is a beneficial owner for the purposes of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| March 11, 2021 Filed Mar 12, 2021 02:37 UTC |
Wicki AndreasDirector
|
SaleCommon Stock | 60,574 | $72.70 | $4,403,729.80 |
DisclosureSEC source: 0001104659-21-035174 · tm219418-1_4seq1.xml · nonDerivative · entry 3 Wicki Andreas · CIK 0001511472 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 520,679 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.40 to $73.35, inclusive. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price within the ranges set forth in footnote four (4) of this Form 4. F2 · ownership.nature: These shares are held by HBM Healthcare Investments (Cayman) Ltd. ("HBM"), of which Mr. Wicki is a member of the board of directors. The board of directors of HBM acts by majority vote, and Mr. Wicki does not have sole voting or investment power with respect to the shares. Mr. Wicki disclaims beneficial ownership of such shares for the purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report on Form 4 shall not be deemed an admission that the reporting person is a beneficial owner for the purposes of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 02:37 UTC |
Wicki AndreasDirector
|
SaleCommon Stock | 76,480 | $71.78 | $5,489,734.40 |
DisclosureSEC source: 0001104659-21-035174 · tm219418-1_4seq1.xml · nonDerivative · entry 2 Wicki Andreas · CIK 0001511472 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 581,253 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.73 to $72.56, inclusive. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price within the ranges set forth in footnote three (3) of this Form 4. F2 · ownership.nature: These shares are held by HBM Healthcare Investments (Cayman) Ltd. ("HBM"), of which Mr. Wicki is a member of the board of directors. The board of directors of HBM acts by majority vote, and Mr. Wicki does not have sole voting or investment power with respect to the shares. Mr. Wicki disclaims beneficial ownership of such shares for the purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report on Form 4 shall not be deemed an admission that the reporting person is a beneficial owner for the purposes of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| March 09, 2021 Filed Mar 12, 2021 02:37 UTC |
Wicki AndreasDirector
|
SaleCommon Stock | 35,137 | $70.90 | $2,491,213.30 |
DisclosureSEC source: 0001104659-21-035174 · tm219418-1_4seq1.xml · nonDerivative · entry 1 Wicki Andreas · CIK 0001511472 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 657,733 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.725 to $71.98, inclusive. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price within the ranges set forth in footnote one (1) of this Form 4. F2 · ownership.nature: These shares are held by HBM Healthcare Investments (Cayman) Ltd. ("HBM"), of which Mr. Wicki is a member of the board of directors. The board of directors of HBM acts by majority vote, and Mr. Wicki does not have sole voting or investment power with respect to the shares. Mr. Wicki disclaims beneficial ownership of such shares for the purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report on Form 4 shall not be deemed an admission that the reporting person is a beneficial owner for the purposes of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 21:12 UTC |
HASTINGS PAUL JDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $13.98 | $0.00 |
DisclosureSEC source: 0001209191-21-018946 · doc4.xml · derivative · entry 3 HASTINGS PAUL J · CIK 0001309702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,000 shares Expires 2021-06-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested and became exercisable in 24 equal monthly installments beginning on July 2, 2011. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 21:12 UTC |
HASTINGS PAUL JDirector
|
SaleCommon Stock | 3,000 | $65.88 | $197,640.00 |
DisclosureSEC source: 0001209191-21-018946 · doc4.xml · nonDerivative · entry 2 HASTINGS PAUL J · CIK 0001309702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,116 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.77 to $66.05, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 21:12 UTC |
HASTINGS PAUL JDirector
|
Exercise / conversionCommon Stock | 3,000 | $13.98 | $41,940.00 |
DisclosureSEC source: 0001209191-21-018946 · doc4.xml · nonDerivative · entry 1 HASTINGS PAUL J · CIK 0001309702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,116 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 16:25 UTC |
LONGENECKER JOHN P PHDDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $13.98 | $0.00 |
DisclosureSEC source: 0001209191-21-016859 · doc4.xml · derivative · entry 3 LONGENECKER JOHN P PHD · CIK 0001288231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2021-06-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in 12 equal monthly installments beginning on July 2, 2011. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 16:25 UTC |
LONGENECKER JOHN P PHDDirector
|
SaleCommon Stock | 5,000 | $72.26 | $361,300.00 |
DisclosureSEC source: 0001209191-21-016859 · doc4.xml · nonDerivative · entry 2 LONGENECKER JOHN P PHD · CIK 0001288231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,757 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.95 to $72.71, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 16:25 UTC |
LONGENECKER JOHN P PHDDirector
|
Exercise / conversionCommon Stock | 5,000 | $13.98 | $69,900.00 |
DisclosureSEC source: 0001209191-21-016859 · doc4.xml · nonDerivative · entry 1 LONGENECKER JOHN P PHD · CIK 0001288231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,757 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2021 Filed Feb 4, 2021 19:58 UTC |
STACK DAVID MDirector · CEO and Chairman
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 21,250 | $0.00 Strike: $10.81 | $0.00 |
DisclosureSEC source: 0001209191-21-007906 · doc4.xml · derivative · entry 12 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,170 Underlying: Common Stock · 21,250 shares Expires 2022-06-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months. Read SEC document |
| February 03, 2021 Filed Feb 4, 2021 19:58 UTC |
STACK DAVID MDirector · CEO and Chairman
|
SaleCommon Stock | 14,350 | $71.42 | $1,024,877.00 |
DisclosureSEC source: 0001209191-21-007906 · doc4.xml · nonDerivative · entry 7 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,061 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.99 to $71.85, inclusive. Read SEC document |
| February 03, 2021 Filed Feb 4, 2021 19:58 UTC |
STACK DAVID MDirector · CEO and Chairman
|
SaleCommon Stock | 6,900 | $70.78 | $488,382.00 |
DisclosureSEC source: 0001209191-21-007906 · doc4.xml · nonDerivative · entry 6 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,411 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.99 to $70.985, inclusive. F3 · balance_after: Reflects the transfer of 98,353 shares of common stock previously held directly by the reporting person to Three Colleens Investment, LLC, an entity through which the reporting person holds such shares of common stock indirectly. Read SEC document |
| February 03, 2021 Filed Feb 4, 2021 19:58 UTC |
STACK DAVID MDirector · CEO and Chairman
|
Exercise / conversionCommon Stock | 21,250 | $10.81 | $229,712.50 |
DisclosureSEC source: 0001209191-21-007906 · doc4.xml · nonDerivative · entry 5 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,311 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| February 02, 2021 Filed Feb 4, 2021 19:58 UTC |
STACK DAVID MDirector · CEO and Chairman
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 21,250 | $0.00 Strike: $10.81 | $0.00 |
DisclosureSEC source: 0001209191-21-007906 · doc4.xml · derivative · entry 11 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,420 Underlying: Common Stock · 21,250 shares Expires 2022-06-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months. Read SEC document |
| February 02, 2021 Filed Feb 4, 2021 19:58 UTC |
STACK DAVID MDirector · CEO and Chairman
|
SaleCommon Stock | 4,100 | $70.20 | $287,820.00 |
DisclosureSEC source: 0001209191-21-007906 · doc4.xml · nonDerivative · entry 4 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,061 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.83 to $70.795, inclusive. Read SEC document |
| February 02, 2021 Filed Feb 4, 2021 19:58 UTC |
STACK DAVID MDirector · CEO and Chairman
|
SaleCommon Stock | 14,250 | $69.38 | $988,665.00 |
DisclosureSEC source: 0001209191-21-007906 · doc4.xml · nonDerivative · entry 3 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,161 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.83 to $69.815, inclusive. Read SEC document |
| February 02, 2021 Filed Feb 4, 2021 19:58 UTC |
STACK DAVID MDirector · CEO and Chairman
|
SaleCommon Stock | 2,900 | $68.41 | $198,389.00 |
DisclosureSEC source: 0001209191-21-007906 · doc4.xml · nonDerivative · entry 2 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,411 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.83 to $68.82, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 4 through 8. Read SEC document |
| February 02, 2021 Filed Feb 4, 2021 19:58 UTC |
STACK DAVID MDirector · CEO and Chairman
|
Exercise / conversionCommon Stock | 21,250 | $10.81 | $229,712.50 |
DisclosureSEC source: 0001209191-21-007906 · doc4.xml · nonDerivative · entry 1 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,311 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F2 · balance_after: Includes 144 shares of common stock acquired under the issuer's employee stock purchase plan in December 2020. F3 · balance_after: Reflects the transfer of 98,353 shares of common stock previously held directly by the reporting person to Three Colleens Investment, LLC, an entity through which the reporting person holds such shares of common stock indirectly. Read SEC document |
| January 06, 2021 Filed Jan 8, 2021 21:39 UTC |
REINHARDT MAXPresident
|
SaleCommon Stock | 110 | $60.81 | $6,689.10 |
DisclosureSEC source: 0001209191-21-002722 · doc4.xml · nonDerivative · entry 1 REINHARDT MAX · CIK 0001780058 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F2 · balance_after: Includes 110 shares of common stock acquired under the issuer's employee stock purchase plan in December 2020. Read SEC document |
| November 16, 2020 Filed Nov 17, 2020 22:39 UTC |
Brege LauraDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $13.98 | $0.00 |
DisclosureSEC source: 0001209191-20-058830 · doc4.xml · derivative · entry 3 Brege Laura · CIK 0001365619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,000 shares Expires 2021-06-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested and became exercisable in 24 equal monthly installments beginning on July 2, 2011. Read SEC document |
| November 16, 2020 Filed Nov 17, 2020 22:39 UTC |
Brege LauraDirector
|
SaleCommon Stock | 12,000 | $65.95 | $791,400.00 |
DisclosureSEC source: 0001209191-20-058830 · doc4.xml · nonDerivative · entry 2 Brege Laura · CIK 0001365619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,921 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.930 to $66.015, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 16, 2020 Filed Nov 17, 2020 22:39 UTC |
Brege LauraDirector
|
Exercise / conversionCommon Stock | 12,000 | $13.98 | $167,760.00 |
DisclosureSEC source: 0001209191-20-058830 · doc4.xml · nonDerivative · entry 1 Brege Laura · CIK 0001365619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,921 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 13, 2020 Filed Nov 17, 2020 22:30 UTC |
WINSTON ROYChief Clinical Officer
|
SaleCommon Stock | 5,000 | $62.00 | $310,000.00 |
DisclosureSEC source: 0001209191-20-058819 · doc4.xml · nonDerivative · entry 1 WINSTON ROY · CIK 0001751757 · Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,785 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F2 · balance_after: Includes 548 shares of common stock acquired under the issuer's employee stock purchase plan in June 2020. Read SEC document |
| November 13, 2020 Filed Nov 17, 2020 22:37 UTC |
RIKER LAURENVice President, Finance
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $10.81 | $0.00 |
DisclosureSEC source: 0001209191-20-058828 · doc4.xml · derivative · entry 3 Riker Lauren Bullaro · CIK 0001545439 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,820 Underlying: Common Stock · 3,000 shares Expires 2022-06-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and vested as to the remaining shares in successive equal monthly installments for the subsequent 36 months. Read SEC document |
| November 13, 2020 Filed Nov 17, 2020 22:37 UTC |
RIKER LAURENVice President, Finance
|
SaleCommon Stock | 3,000 | $63.81 | $191,430.00 |
DisclosureSEC source: 0001209191-20-058828 · doc4.xml · nonDerivative · entry 2 Riker Lauren Bullaro · CIK 0001545439 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,181 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| November 13, 2020 Filed Nov 17, 2020 22:37 UTC |
RIKER LAURENVice President, Finance
|
Exercise / conversionCommon Stock | 3,000 | $10.81 | $32,430.00 |
DisclosureSEC source: 0001209191-20-058828 · doc4.xml · nonDerivative · entry 1 Riker Lauren Bullaro · CIK 0001545439 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,181 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| November 13, 2020 Filed Nov 17, 2020 22:28 UTC |
REINHARDT MAXPresident
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $42.54 | $0.00 |
DisclosureSEC source: 0001209191-20-058818 · doc4.xml · derivative · entry 4 REINHARDT MAX · CIK 0001780058 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 25,000 shares Expires 2029-07-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| November 13, 2020 Filed Nov 17, 2020 22:28 UTC |
REINHARDT MAXPresident
|
SaleCommon Stock | 21,000 | $63.51 | $1,333,710.00 |
DisclosureSEC source: 0001209191-20-058818 · doc4.xml · nonDerivative · entry 3 REINHARDT MAX · CIK 0001780058 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.005 to $63.990, inclusive. Read SEC document |
| November 13, 2020 Filed Nov 17, 2020 22:28 UTC |
REINHARDT MAXPresident
|
SaleCommon Stock | 4,000 | $62.67 | $250,680.00 |
DisclosureSEC source: 0001209191-20-058818 · doc4.xml · nonDerivative · entry 2 REINHARDT MAX · CIK 0001780058 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.000 to $62.995, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3. Read SEC document |
| November 13, 2020 Filed Nov 17, 2020 22:28 UTC |
REINHARDT MAXPresident
|
Exercise / conversionCommon Stock | 25,000 | $42.54 | $1,063,500.00 |
DisclosureSEC source: 0001209191-20-058818 · doc4.xml · nonDerivative · entry 1 REINHARDT MAX · CIK 0001780058 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| October 16, 2020 Filed Oct 16, 2020 16:26 UTC |
STACK DAVID MDirector · CEO and Chairman
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $10.81 | $0.00 |
DisclosureSEC source: 0001209191-20-055054 · doc4.xml · derivative · entry 11 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,670 Underlying: Common Stock · 30,000 shares Expires 2022-06-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months. Read SEC document |
| October 16, 2020 Filed Oct 16, 2020 16:26 UTC |
STACK DAVID MDirector · CEO and Chairman
|
SaleCommon Stock | 30,000 | $55.56 | $1,666,800.00 |
DisclosureSEC source: 0001209191-20-055054 · doc4.xml · nonDerivative · entry 6 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,377 F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| October 16, 2020 Filed Oct 16, 2020 16:26 UTC |
STACK DAVID MDirector · CEO and Chairman
|
Exercise / conversionCommon Stock | 30,000 | $10.81 | $324,300.00 |
DisclosureSEC source: 0001209191-20-055054 · doc4.xml · nonDerivative · entry 5 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,377 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| October 15, 2020 Filed Oct 16, 2020 16:26 UTC |
STACK DAVID MDirector · CEO and Chairman
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $10.81 | $0.00 |
DisclosureSEC source: 0001209191-20-055054 · doc4.xml · derivative · entry 10 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,670 Underlying: Common Stock · 30,000 shares Expires 2022-06-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months. Read SEC document |
| October 15, 2020 Filed Oct 16, 2020 16:26 UTC |
STACK DAVID MDirector · CEO and Chairman
|
SaleCommon Stock | 30,000 | $55.00 | $1,650,000.00 |
DisclosureSEC source: 0001209191-20-055054 · doc4.xml · nonDerivative · entry 4 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,377 F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.